Studies link HIV drugs and bone density problems. Research examining HIV in children and women.
Several recent studies add to the evidence that HIV infection and possibly highly active antiretroviral treatment increase risks of bone mass problems among women and children. The research suggests that clinicians should watch for bone density loss and osteoporosis risk factors among the HIV-infected patients.
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D015519:Bone Density; D002648:Child; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D012307:Risk Factors